Icar-C and Prolixin Decanoate
Determining the interaction of Icar-C and Prolixin Decanoate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:A case report suggests that ascorbic acid may reduce the therapeutic effect of fluphenazine.
- Dysken MW, Cumming RJ, Channon RA, Davis JM "Drug interaction between ascorbic acid and fluphenazine." JAMA 241 (1979): 2008
Generic Name: ascorbic acid / carbonyl iron
Brand name: Fe C, Icar-C, Vitron-C
Synonyms: n.a.
Generic Name: fluphenazine
Brand name: Permitil, Prolixin, Prolixin Decanoate, Prolixin Enanthate
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Icar-C-Prolixin Oral Concentrate
- Icar-C-Proloprim
- Icar-C-Promacot
- Icar-C-Promacot Injection, Intravenous
- Icar-C-Promacta
- Icar-C-Promacta (Eltrombopag Powder for Suspension)
- Prolixin Decanoate-Icatibant
- Prolixin Decanoate-Icatibant Acetate
- Prolixin Decanoate-Icatibant Injection
- Prolixin Decanoate-Icatibant Subcutaneous
- Prolixin Decanoate-ICG for Injection Set
- Prolixin Decanoate-Iclevia